Importantly, recent studies identified quite some cases of PAX1 mutations associated Severe Combined Immunodeficiency (SCID) patients with Otofaciocervical Syndrome Type 2 (OTFCS2) [20–24]. This evidence concerns the gene PAX1 and severe combined immunodeficiency.